Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Glaxo consolidates DTC media at Media Edge

Published on .

Glaxo Wellcome has consolidated its $150 million to $200 million direct-to-consumer media buying and planning account at the Media Edge, New York. The decision follows a four-month review. Media Edge, a unit of Young & Rubicam, had handled buying for Glaxo, while planning was split among at least four agencies. In a related move, Glaxo shifted its direct-response media assignment to Media Direct Partners, New York, a unit of Interpublic Group of Cos. Wunderman Cato Johnson, New York, another Y&R unit, had handled.

Copyright March 1999, Crain Communications Inc.

Most Popular
In this article: